Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 22, 2019
[ Wed, May 22nd 2019
] - WOPRAI
Tue, May 21, 2019
[ Tue, May 21st 2019
] - WOPRAI
[ Tue, May 21st 2019
] - WOPRAI
[ Tue, May 21st 2019
] - WOPRAI
[ Tue, May 21st 2019
] - WOPRAI
[ Tue, May 21st 2019
] - WOPRAI
[ Tue, May 21st 2019
] - WOPRAI
[ Tue, May 21st 2019
] - WOPRAI
[ Tue, May 21st 2019
] - WOPRAI
Mon, May 20, 2019
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
[ Mon, May 20th 2019
] - WOPRAI
Fri, May 17, 2019
[ Fri, May 17th 2019
] - WOPRAI
[ Fri, May 17th 2019
] - WOPRAI
Martin Auster Upgraded (UTHR) to Hold and Decreased Target to $94 on, May 17th, 2019
Martin Auster of UBS, Upgraded "United Therapeutics Corporation" (UTHR) to Hold and Decreased Target from $115 to $94 on, May 17th, 2019.
Martin has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 1 agrees with Martin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- M. Auster of "Credit Suisse" Upgraded from Sell to Hold on, Thursday, May 9th, 2019
These are the ratings of the 2 analyists that currently disagree with Martin
- Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $273 on, Thursday, May 2nd, 2019
- Geoff Meacham of "Barclays" Maintained at Sell with Decreased Target to $95 on, Friday, March 1st, 2019
